跳至主要内容
临床试验/NL-OMON39562
NL-OMON39562已完成不适用

DUrable Polymer-based STent CHallenge of Promus ElemEnt versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All-Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2) - DUTCH PEERS (TWENTE-2)

Medisch Spectrum Twente0 个研究点目标入组 1,788 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,788

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • Minimum age of 18 years * Coronary artery disease and lesion(s) eligable for treatment with drug eluting stents according to clinical guidelines and/or the operators* judgement * Patient is willing and able to cooperate with study procedures and required follow-up visits; and patient has been informed and agrees on the participation by signing an EC approved written informed consent.

排除标准

  • Participation in another randomized drug or device study before reaching primary endpoint * Planned surgery within 6 months of PCI unless dual antiplatelet therapy is maintained throughout the peri-surgical period * Intolerance to a P2Y12 receptor antagonist that results in the patient*s inability to adhere to dual-antiplatelet therapy, or intolerance to aspirin, heparin, or components of the two DES examined * Known pregnancy * Life expectancy of less than 1 year

研究者

相似试验